A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
GlobalData on MSN21h
Wellumio’s portable MRI device trial enrols first subject in AustraliaWellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback